A tailwind from a backlog of surgical procedures could improve valuations for medtech stocks, says Anthony Petrone, managing director equity research at Mizuho Americas. His three picks are: Boston Scientific (BSX, NYSE), PT $80, GE Healthcare (GEHC, Nasdaq), PT $96, Bull chase PT $115, and LivaNova (LIVN, Nasdaq) , PT $75.
Watch/Read More
Categories
Hot Picks: A backlog in surgical procedures could drive these stocks – Video
